Ron Strider
Well-Known Member
I want to follow up on two subjects that generate a lot of comments and investment inquiries from my Seeking Alpha articles:
· Pharmaceutical companies developing cannabis-based products, and
· Investment opportunities in Israel-based companies developing and commercializing medicines with cannabis ingredients.
Israeli scientists, revered worldwide as biomed and hi-tech innovators, are leaders of this new intersection of cannabis and medicine. Investing in pharmaceutical companies working with cannabis is the smartest way forward, because most other companies in the recreational marijuana industry are a mess. People are dismayed or exhausted with recreational marijuana stocks. MMJ R&D is flourishing in Israel, because the government encourages the scientists and funds selected research. Second, much of the work begins in university laboratories and the relationship continues after scientist's moves his work into the private sector. Beware, however, because neither the science nor U S legal acceptability can be taken for granted.
The issues pharmaceutical companies working with cannabis face include the following. Scientists have identified only some 20 of the 142 cannabinoids found in marijuana; and next, they must match them to the exact biological function in the human body. Then matching the right cannabinoids to the right illness is another yeoman's task. Extracting them, encapsulating them and creating delivery mechanisms is another issue. After all this, consider the fact that health ministries and the FDA only permit a tiny amount of purified isolated molecules in a cannabis-based drug. One Israeli CEO in pharma-cannabis warns, "The only way to make cannabis an FDA drug and prescribe it as a pharmaceutical product is to isolate each one of the cannabinoids and purify it to almost 100%."
News Moderator: Ron Strider 420 MAGAZINE ®
Full Article: Israel Cannabis Startups Are Flourishing | Seeking Alpha
Author: Dr. Harold Goldmeier
Contact: Contact us | Seeking Alpha
Photo Credit: None Found
Website: Stock Market Insights | Seeking Alpha
· Pharmaceutical companies developing cannabis-based products, and
· Investment opportunities in Israel-based companies developing and commercializing medicines with cannabis ingredients.
Israeli scientists, revered worldwide as biomed and hi-tech innovators, are leaders of this new intersection of cannabis and medicine. Investing in pharmaceutical companies working with cannabis is the smartest way forward, because most other companies in the recreational marijuana industry are a mess. People are dismayed or exhausted with recreational marijuana stocks. MMJ R&D is flourishing in Israel, because the government encourages the scientists and funds selected research. Second, much of the work begins in university laboratories and the relationship continues after scientist's moves his work into the private sector. Beware, however, because neither the science nor U S legal acceptability can be taken for granted.
The issues pharmaceutical companies working with cannabis face include the following. Scientists have identified only some 20 of the 142 cannabinoids found in marijuana; and next, they must match them to the exact biological function in the human body. Then matching the right cannabinoids to the right illness is another yeoman's task. Extracting them, encapsulating them and creating delivery mechanisms is another issue. After all this, consider the fact that health ministries and the FDA only permit a tiny amount of purified isolated molecules in a cannabis-based drug. One Israeli CEO in pharma-cannabis warns, "The only way to make cannabis an FDA drug and prescribe it as a pharmaceutical product is to isolate each one of the cannabinoids and purify it to almost 100%."
News Moderator: Ron Strider 420 MAGAZINE ®
Full Article: Israel Cannabis Startups Are Flourishing | Seeking Alpha
Author: Dr. Harold Goldmeier
Contact: Contact us | Seeking Alpha
Photo Credit: None Found
Website: Stock Market Insights | Seeking Alpha